0.82 and for activities and quality of life " />
Display options
Cite
Pelle T, Bevers K, van den Hoogen F, et al. Economic evaluation of the dr. Bart app in people with knee and/or hip osteoarthritis. Arthritis Care Res (Hoboken). 2021;doi: 10.1002/acr.24608.
Pelle, T., Bevers, K., van den Hoogen, F., van der Palen, J., & van den Ende, C. (2021). Economic evaluation of the dr. Bart app in people with knee and/or hip osteoarthritis. Arthritis care & research, . https://doi.org/10.1002/acr.24608
Pelle, Tim, et al. "Economic evaluation of the dr. Bart app in people with knee and/or hip osteoarthritis." Arthritis care & research vol. (2021). doi: https://doi.org/10.1002/acr.24608
Pelle T, Bevers K, van den Hoogen F, van der Palen J, van den Ende C. Economic evaluation of the dr. Bart app in people with knee and/or hip osteoarthritis. Arthritis Care Res (Hoboken). 2021 Mar 25; doi: 10.1002/acr.24608. Epub 2021 Mar 25. PMID: 33768675.
Copy Download .nbib Format: NLM
Share it on

Arthritis Care Res (Hoboken). 2021 Mar 25; doi: 10.1002/acr.24608. Epub 2021 Mar 25.

Economic evaluation of the dr. Bart app in people with knee and/or hip osteoarthritis.

Arthritis care & research

Tim Pelle, Karen Bevers, Frank van den Hoogen, Job van der Palen, Cornelia van den Ende

Affiliations

  1. Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.
  2. Department of Rheumatic Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.
  3. Department of Research Methodology, Measurement, and Data-Analysis, Behavioural, Management and Social Sciences, University of Twente, Enschede, The Netherlands.
  4. Medical School Twente, Medisch Spectrum Twente, Enschede, the Netherlands.

PMID: 33768675 DOI: 10.1002/acr.24608

Abstract

OBJECTIVE: To evaluate the cost-utility and cost-effectiveness of the dr. Bart app compared to usual care in people with knee/hip OA, applying a health care payer perspective.

METHODS: This economic evaluation was conducted alongside a 6-month randomized controlled trial, involving 427 participants. The dr. Bart app is a stand-alone eHealth application which invites users to select pre-formulated goals (i.e. "tiny habits") and triggers to a healthier lifestyle. Self-reported outcome measures were health care costs, quality-adjusted life years (QALYs) according to the EuroQol (EQ-5D-3L), and the EuroQol Visual Analogue Scale (QALY-VAS), patient activation measure (PAM-13) and five subscales of KOOS/HOOS. Missing data were multiply imputed and bootstrapping was used to estimate statistical uncertainty.

RESULTS: Mean age of participants was 62.1(SD 7.3) years, with the majority being female(72%). Health care costs were lower for the intervention group(€-22 (95% CI: -36; -3)). For QALY and QALY-VAS, the probability of the dr. Bart app being cost-effective compared to usual care was 0.71 and 0.67 at a willingness to pay(WTP) of €10.000 and 0.64 and 0.56 at WTP €80.000, respectively. For self-management behaviour, symptoms, pain and ADL, the probability that dr. Bart app was cost-effective was >0.82 and for activities and quality of life <0.40, regardless of WTPs.

CONCLUSION: This economic evaluation showed that costs were lower for the dr. Bart app group compared to usual care. Given the non-invasive character of the intervention and the moderate probability of being cost-effective for the majority of outcomes, the dr. Bart app has the potential to serve as a tool to provide education and goal setting regarding OA and its treatment options.

This article is protected by copyright. All rights reserved.

Publication Types